Skip to main content
. 2017 Dec 29;7(12):e019170. doi: 10.1136/bmjopen-2017-019170

Table 4.

Power (%) to detect prevalence ratios of macrolide and β-lactamase resistance in 200 Escherichia coli and 200 Streptococcus pneumoniae isolates per treatment group

Resistance prevalence (%) in placebo group
Resistance prevalence (%) in azithromycin group 10 20 30 40 50 60 70
 10
 20 80
 30 >99 64
 40 >99 99 55
 50 >99 >99 98 48
 60 >99 >99 >99 >99 52
 70 >99 >99 >99 >99 98 55
 80 >99 >99 >99 >99 >99 99 64